PDS Biotechnology Statistics Share Statistics PDS Biotechnology has 46.67M
shares outstanding. The number of shares has increased by 24.15%
in one year.
Shares Outstanding 46.67M Shares Change (YoY) 24.15% Shares Change (QoQ) 2.51% Owned by Institutions (%) 20.3% Shares Floating 45.23M Failed to Deliver (FTD) Shares 15,669 FTD / Avg. Volume 2.79%
Short Selling Information The latest short interest is 1.75M, so 3.76% of the outstanding
shares have been sold short.
Short Interest 1.75M Short % of Shares Out 3.76% Short % of Float 3.88% Short Ratio (days to cover) 4.35
Valuation Ratios The PE ratio is -1.58 and the forward
PE ratio is -1.41.
PDS Biotechnology's PEG ratio is
0.06.
PE Ratio -1.58 Forward PE -1.41 PS Ratio 0 Forward PS 4.2 PB Ratio 3.13 P/FCF Ratio -1.69 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for PDS Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.64,
with a Debt / Equity ratio of 1.15.
Current Ratio 2.64 Quick Ratio 2.64 Debt / Equity 1.15 Debt / EBITDA -0.65 Debt / FCF -0.62 Interest Coverage -7.77
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.57M Employee Count 24 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -869K Effective Tax Rate 2.26%
Stock Price Statistics The stock price has increased by -69.73% in the
last 52 weeks. The beta is 1.15, so PDS Biotechnology's
price volatility has been higher than the market average.
Beta 1.15 52-Week Price Change -69.73% 50-Day Moving Average 1.16 200-Day Moving Average 1.36 Relative Strength Index (RSI) 35.35 Average Volume (20 Days) 561,327
Income Statement
Revenue n/a Gross Profit -59.79K Operating Income -36.32M Net Income -37.61M EBITDA -33.75M EBIT -33.81M Earnings Per Share (EPS) -1.03
Full Income Statement Balance Sheet The company has 41.69M in cash and 21.83M in
debt, giving a net cash position of 19.86M.
Cash & Cash Equivalents 41.69M Total Debt 21.83M Net Cash 19.86M Retained Earnings -182.11M Total Assets 40.48M Working Capital 20.34M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -35.03M
and capital expenditures -29K, giving a free cash flow of -35.06M.
Operating Cash Flow -35.03M Capital Expenditures -29K Free Cash Flow -35.06M FCF Per Share -0.96
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PDSB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PDSB is $10,
which is 880.4% higher than the current price. The consensus rating is "Buy".
Price Target $10 Price Target Difference 880.4% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 18, 2019. It was a
backward
split with a ratio of 1:20.
Last Split Date Mar 18, 2019 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -7.61 Piotroski F-Score 3
